ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 55 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $30,000 | +87.5% | 32,000 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $16,000 | -36.0% | 32,000 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $25,000 | -13.8% | 32,000 | -40.2% | 0.00% | 0.0% |
| Q2 2020 | $29,000 | +52.6% | 53,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $19,000 | -48.6% | 53,500 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $37,000 | -2.6% | 53,500 | 0.0% | 0.00% | -75.0% |
| Q3 2019 | $38,000 | -54.2% | 53,500 | -15.7% | 0.00% | -50.0% |
| Q2 2019 | $83,000 | -38.1% | 63,500 | -0.3% | 0.01% | -46.7% |
| Q1 2019 | $134,000 | -10.1% | 63,700 | -3.8% | 0.02% | -21.1% |
| Q4 2018 | $149,000 | -35.8% | 66,200 | 0.0% | 0.02% | -24.0% |
| Q3 2018 | $232,000 | +14.3% | 66,200 | +4.3% | 0.02% | +66.7% |
| Q2 2018 | $203,000 | – | 63,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |